Hypertension and hypertensive heart disease in African women

Clinical Research in Cardiology

Volumn 103, Issue 7, 2014, Pages 515-523

  Sliwa, Karen ^a,b,c   Ojji, Dike ^d   Bachelier, Katrin ^e   Böhm, Michael ^e   Damasceno, Albertino ^f   Stewart, Simon ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF ABUJA   (Nigeria)

^e SAARLAND UNIVERSITY   (Germany)

^f Eduardo University   (Mozambique)

Author keywords

Africa; Black women; Hypertension; Hypertensive heart disease

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; LIPID; METHYLDOPA; NIFEDIPINE; PERINDOPRIL; THIAZIDE DIURETIC AGENT;

ACUTE CORONARY SYNDROME; AFRICA; AFRICAN AMERICAN; ANTHROPOMETRY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ECLAMPSIA; ELECTROCARDIOGRAM; EPIDEMIC; EUROPEAN AMERICAN; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; HYPERTENSIVE HEART DIEASE; LIFESTYLE; MATERNAL HYPERTENSION; MATERNAL MORTALITY; MATERNAL WELFARE; PERIPARTUM CARDIOMYOPATHY; PHYSICIAN; POPULATION; PREECLAMPSIA; PREGNANCY; PRENATAL GROWTH; PREVALENCE; PRIMARY PREVENTION; REVIEW; SALT INTAKE; SECONDARY PREVENTION; SEX DIFFERENCE; SMOKING; SODIUM RESTRICTION; AGE; BLACK PERSON; CARDIOVASCULAR DISEASES; COMPLICATION; HEART DISEASES; HYPERTENSION, PREGNANCY-INDUCED; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; CARDIOVASCULAR DISEASES; FEMALE; HEART DISEASES; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; RISK FACTORS; STROKE;

EID: 84902769753     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0660-z     Document Type: Review

References (62)

1. He FJ, MacGregor GA (2007) Blood pressure is the most important cause of death and disability in the world. Eur Heart J Suppl 9:B23-B28
2. World Health Organization (2008) 2008-2013 Action plan for the global strategy for the prevention and control of non-communicable diseases. http://www.who.int/nmh/actionplan-PC-NCD-2008.pdf. Accessed July 2012
3. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB (2012) Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 307:1273-1283
4. Law M, Morris J, Wald N (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:1245-1253
5. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K (2007) The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 370:1929-1938 (Pubitemid 350192633)
6. Sliwa K, Stewart S, Gersh BJ (2011) Hypertension a global perspective. Circulation 123:2892-2896
7. Gersh BJ, Sliwa K, Mayosi BM, Yusuf S (2010) Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 31:642-648
8. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D (2009) The burden of non-communicable diseases in South Africa. Lancet 374:934-947
9. Njelekela MA, Mpembeni R, Muhihi A, Mligiliche NL, Spiegelman D, Hertzmark E, Liu E, Finkelstein JL, Fawzi WW, Willett WC, Mtabaji J (2009) Gender-related differences in the prevalence of cardiovascular disease risk factors and their correlates in urban Tanzania. BMC Cardiovasc Disord 9:30
10. Stewart S, Carrington M, Pretorius S, Methusi P, Sliwa K (2011) Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J 32:492-499
11. Cooper RS, Osotimehin B, Kaufman JS, Forrester T (1998) Disease burden in sub-Saharan Africa: what should we conclude in the absence of data? Lancet 351:208-210 (Pubitemid 28037018)
12. Addo J, Smeeth L, Leon DA (2007) Hypertension in sub-saharan Africa: a systematic review. Hypertension 50:1012-1018 (Pubitemid 350172921)
13. Stewart S, Carrington MJ, Pretorius S, Ogah OS, Blauwet L, Antras-Ferry J, Sliwa K (2012) Elevated risk factors but low burden of heart disease in urban African primary care patients: a fundamental role for primary prevention. Int J Cardiol 158:2005-2010
14. Selassie A, Wagner CS, Laken ML, Ferguson ML, Ferdinand KC, Egan BM (2011) Progression is accelerated from prehypertension to hypertension in blacks. Hypertension 58:579-587
15. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, Stewart S (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 371:915-922 (Pubitemid 351375275)
16. Olatunbosun ST, Kaufman JS, Cooper RS, Bella AF (2000) Hypertension in a black population: prevalence and biosocial determinants of high blood pressure in a group of urban Nigerians. J Hum Hypertens 14:249-257 (Pubitemid 30209574)
17. Salako BL, Ogah OS, Adebiyi AA, Adedapo KS, Bekibele CO, Oluleye TS, Okpechi I (2007) Unexpectedly high prevalence of target-organ damage in newly diagnosed Nigerians with hypertension. Cardiovasc J Afr 18:77-83
18. Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, Jinagouda S, Shea S (2004) Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). Am J Hypertens 17:963-970 (Pubitemid 39361670)
19. Akinkugbe OO, Ojo AO (1968) The systemic blood pressure in a rural Nigerian population. Trop Geogr Med 20:347-356
20. Ogah OS (2006) Hypertension in sub-Saharan African populations: the burden of hypertension in Nigeria. Ethn Dis 16:765
21. Onwubere BJ, Ejim EC, Okafor CI, Emehel A, Mbah AU, Onyia U, Mendis S (2011) Pattern of blood pressure indices among the residents of a rural community in South East Nigeria. Int J Hypertens 2011:621074
22. Peer N, Steyn K, Dennison CR, Levitt NS, Nyo MT, Nel JH, Commerford PJ, Fourie JM, Hill MN (2008) Determinants of target organ damage in black hypertensive patients attending primary health care services in Cape Town: the Hi-Hi study. Am J Hypertens 21:896-902
23. Stewart S, Libhaber E, Carrington M, Damasceno A, Abbasi H, Hansen C, Wilkinson D, Sliwa K (2011) The clinical consequences and challenges of hypertension in urban-dwelling black Africans: insights from the Heart of Soweto Study. Int J Cardiol 146:22-27
24. Huxley R, Neil A, Collins R (2002) Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet 360: 659-665 (Pubitemid 35232333)
25. Kruger R, Kruger HS, Macintyre UE (2006) The determinants of overweight and obesity among 10- to 15-year-old schoolchildren in the North West Province, South Africa-the THUSA BANA (Transition and Health during Urbanisation of South Africans; BANA, children) study. Public Health Nutr 9:351-358 (Pubitemid 43845068)
26. Cruickshank JK, Mzayek F, Liu L, Kieltyka L, Sherwin R, Webber LS, Srinavasan SR, Berenson GS (2005) Origins of the "black/white" difference in blood pressure: roles of birth weight, postnatal growth, early blood pressure, and adolescent body size: the Bogalusa heart study. Circulation 111:1932-1937 (Pubitemid 40570212)
27. Barker DJP (1998) Mothers, babies and health in later life, 2nd edn. Churchill Livingstone, pp 1-127
28. Seely EW, Ecker J (2011) Clinical practice. Chronic hypertension in pregnancy. N Engl J Med 365:439-446
29. Karthikeyan VJ, Blann AD, Baghdadi S, Lane DA, Gareth Beevers D, Lip GY (2011) Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factor. Clin Res Cardiol 100:531-537
30. Sliwa K, Forster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, Ansari AA (2006) Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27:441-446 (Pubitemid 43209169)
31. Sliwa K, Hilfiker-Kleiner D, Petrie M, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi B, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray J (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur J Heart Fail 12:767-778
32. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A (2005) Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111:2050-2055 (Pubitemid 40577899)
33. Duran N, Gunes H, Duran I, Biteker M, Ozkan M (2008) Predictors of prognosis in patients with peripartum cardiomyopathy. Int J Gynaecol Obstet 101:137-140
34. Fett JD, Christie LG, Carraway RD, Murphy JG (2005) Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80:1602-1606 (Pubitemid 41747062)
35. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561-1566 (Pubitemid 20176696)
36. Koren MJ, Ulin RJ, Koren AT, Laragh JH, Devereux RB (2002) Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 15:1021-1028 (Pubitemid 35397534)
37. Weinberg EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, Douglas PS, Lorell BH (1999) Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34:264-273
38. Vasan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, Murabito JM, Sam F, Colucci WS, Wilson PW (2004) Relations of serum aldosterone to cardiac structure: genderrelated differences in the Framingham Heart Study. Hypertension 43:957-962 (Pubitemid 38579898)
39. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, Sliwa K (2008) Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 118:2360-2367
40. Opie LH, Seedat YK (2005) Hypertension in sub-Saharan African populations. Circulation 112:3562-3568 (Pubitemid 43739533)
41. Libhaber EN, Libhaber CD, Candy GP, Sliwa K, Kachope J, Hlatshwayo NM, Puane MO, Woodiwiss AJ, Norton GR, Essop MR, Sareli P (2004) Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry. Am J Hypertens 17:428-432 (Pubitemid 38529965)
42. Skudicky D, Sareli P, Libhaber E, Candy G, Radevski I, Valtchanova Z, Tshele E, Thijs L, Wang JG, Staessen JA (2002) Relationship between treatment-induced changes in left ventricular mass and blood pressure in black African hypertensive patients: results of the Baragwanath Trial. Circulation 105:830-836 (Pubitemid 34174923)
43. Kotchen TA, Kotchen JM, Grim CE, Krishnaswami S, Kidambi S (2009) Aldosterone and alterations of hypertension-related vascular function in African Americans. Am J Hypertens 22:319-324
44. Rodrigues SL, Angelo LC, Baldo MP, Dantas EM, Barcelos AM, Pereira AC, Krieger JE, Mill JG (2013) Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study. Clin Res Cardiol 102:653-659
45. Sliwa K, Lee G, Carrington M, Obel P, Okreglicki A, Stewart S (2013) Redefining the ECG in urban South Africans: electrocardiographic findings in heart disease-free Africans. Int J Cardiol 167:2204-2209
46. Galasko G, Collinson PO, Barnes SC, Gaze D, Lahiri A, Senior R (2007) Comparison of the clinical utility of atrial and B type natriuretic peptide measurement for the diagnosis of systolic dysfunction in a low-risk population. J Clin Pathol 60:570-572 (Pubitemid 46867173)
47. Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, Evans DB (2003) Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovasculardisease risk. Lancet 361:717-725 (Pubitemid 36293625)
48. Kolo P, Omotoso A, Katibi I, Sanya E, Adamu U, Fasae A, Aigbe I (2008) Gender differences in left ventricular size and geometric pattern of hypertension subjects. Cardiology 4:11-15
49. Montgomery AA, Fahey T, Peters TJ, MacIntosh C, Sharp DJ (2000) Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 320:686-690 (Pubitemid 30179394)
50. Steyn K, Fourie J, Temple N (2006) Chronic diseases of lifestyle in South Africa: 1995-2005. South African Medical Research Council, Cape Town
51. Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T (2010) Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 3:CD005182
52. Shulman N, Tuttle E Jr, Entwisle G, Apostolides A, Oberman A, Schnaper HW, Kass EH, Taylor JO, Polk BF, Stamler J (1988) Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 259:2113-2122 (Pubitemid 18088499)
53. Charlton KE, Steyn K, Levitt NS, Zulu JV, Jonathan D, Veldman FJ, Nel JH (2005) Diet and blood pressure in South Africa: intake of foods containing sodium, potassium, calcium, and magnesium in three ethnic groups. Nutrition 21:39-50 (Pubitemid 40127564)
54. Bertram MY, Steyn K, Wentzel-Viljoen E, Tollman S, Hofman KJ (2012) Reducing the sodium content of high-salt foods: effect on cardiovascular disease in South Africa. S Afr Med J 102:743-745
55. MacGregor GA, Markandu ND, Best FE, Elder DM, Cam JM, Sagnella GA, Squires M (1982) Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet 1:351-355
56. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 289:2560-2572 (Pubitemid 37430158)
57. ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-2997
58. Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG (2003) Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163:525-541 (Pubitemid 36314340)
59. Cushman WC, Reda DJ, Perry HM, Williams D, Abdellatif M, Materson BJ (2000) Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 160:825-831 (Pubitemid 30165243)
60. B Vogel, Kirschberger M, Zeier M. (2013). Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol Oct 15 (Epub ahead of print)
61. Sliwa K, Stewart S (2011) A low-cost solar-powered blood-pressure device. Lancet 378:647-648
62. World Health Organization (2011) Noncommunicable disease country specific profiles 2011 (WHO Global Report)